BioRestorative Therapies, Inc. ($BRTX) Insider Transactions

Last updated: 2026-03-14 11:09 UTC | Total transactions: 27

In the last 12 months, insiders at BioRestorative Therapies, Inc. ($BRTX) filed 27 transactions with the SEC: 7 open-market purchases totaling $378,507 and 1 sales totaling $1,757. Net insider sentiment: net buying.

BioRestorative Therapies, Inc. operates in the Services-misc health & allied services, nec industry (Industrial Applications and Services sector).

Most Active Insiders

View all SEC Filings for BioRestorative Therapies, Inc. (BRTX).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Oct. 6, 2025 ALSTODT LANCE President, CEO, COB A Warrant 11719 $0.00 11,719.0000 9,116,172 9999.99% 0.13%
Oct. 6, 2025 ALSTODT LANCE President, CEO, COB A Common Stock 15625 $1.60 187,497.0000 9,116,172 9.09% 0.17%
Oct. 6, 2025 Silva Francisco VP of Research and Development A Warrant 11719 $0.00 11,719.0000 9,116,172 9999.99% 0.13%
Oct. 6, 2025 Silva Francisco VP of Research and Development A Comon Stock 11719 $1.60 171,384.0000 9,116,172 7.34% 0.13%
Feb. 14, 2025 Silva Francisco VP of Research and Development A Stock Option 768979 $0.00 1,606,082.0000 7,763,932 91.86% 9.90%
Feb. 14, 2025 ALSTODT LANCE President, CEO, COB A Stock Option 791885 $0.00 1,672,781.0000 7,763,932 89.90% 10.20%
Feb. 14, 2025 Rosa David A Not found A Stock Option 52632 $0.00 174,796.0000 7,763,932 43.08% 0.68%
Feb. 14, 2025 Williams Patrick F. Not found A Stock Option 52632 $0.00 174,796.0000 7,763,932 43.08% 0.68%
Feb. 14, 2025 Kukekov Nickolay V. Not found A Stock Option 52632 $0.00 189,542.0000 7,763,932 38.44% 0.68%
Feb. 14, 2025 Kristal Robert Eugene Chief Financial Officer A Stock Option 166492 $0.00 529,108.0000 7,763,932 45.91% 2.14%
Oct. 28, 2024 Broadrick Dale Not found S Common Stock 1112 $1.58 923,905.0000 8,121,499 0.12% 0.01%
April 8, 2024 Silva Francisco VP of Research and Development P Common Stock 1232 $1.17 161,295.0000 4,218,347 0.77% 0.03%
April 9, 2024 Silva Francisco VP of Research and Development P Common Stock 6600 $1.25 167,895.0000 4,218,347 4.09% 0.16%
April 8, 2024 Silva Francisco VP of Research and Development P Common Stock 476 $1.13 160,063.0000 4,218,347 0.30% 0.01%
March 18, 2024 Silva Francisco VP of Research and Development F Common Stock 17193 $1.39 159,587.0000 4,218,347 9.73% 0.41%
March 18, 2024 ALSTODT LANCE President, CEO, COB F Common Stock 17633 $1.39 171,872.0000 4,218,347 9.30% 0.42%
Feb. 13, 2024 Kristal Robert Eugene Chief Financial Officer A Stock Option 263158 $0.00 362,616.0000 4,218,347 264.59% 6.24%
Feb. 13, 2024 Silva Francisco VP of Research and Development A Stock Option 394737 $0.00 837,116.0000 4,218,347 89.23% 9.36%
Feb. 13, 2024 ALSTODT LANCE President, CEO, COB A Stock Option 438596 $0.00 880,896.0000 4,218,347 99.16% 10.40%
Feb. 13, 2024 Paccasassi Robert VP, QA and Reg Compliance A Stock Option 219298 $0.00 316,543.0000 4,218,347 225.51% 5.20%
Feb. 13, 2024 Kukekov Nickolay V. Not found A Stock Option 79646 $0.00 136,910.0000 4,218,347 139.09% 1.89%
Feb. 13, 2024 Williams Patrick F. Not found A Stock Option 79646 $0.00 122,164.0000 4,218,347 187.32% 1.89%
Feb. 13, 2024 Rosa David A Not found A Stock Option 79646 $0.00 122,164.0000 4,218,347 187.32% 1.89%
Feb. 8, 2024 Broadrick Dale Not found P Common Stock 73959 $1.25 1,316,948.0000 4,218,347 5.95% 1.75%
Feb. 9, 2024 Broadrick Dale Not found P Common Stock 86041 $1.32 1,316,948.0000 4,218,347 6.99% 2.04%
Feb. 7, 2024 Broadrick Dale Not found P Common Stock 36374 $1.38 681,391.0000 4,218,347 5.64% 0.86%
Feb. 8, 2024 Broadrick Dale Not found P Common Stock 83626 $1.34 765,017.0000 4,218,347 12.27% 1.98%